Trump Drug Pricing Deal with Dr. Mehmet Oz: Understanding the New Rules for Wegovy, Ozempic, and Medicare Patients
Breaking news — November 6, 2025, 10 a.m. ET: President Donald Trump and CMS Administrator Dr. Mehmet Oz announced a new Trump drug pricing deal with Eli Lilly and Novo Nordisk to cut the cost of popular weight-loss drugs, including Wegovy and Ozempic. The plan introduces Medicare copays as low as $50 a month and a new TrumpRx platform for direct patient access. Here’s what this means for health advocates, patients, and the future of medication affordability.




